KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Gains from Investment Securities (2016 - 2025)

Pfizer (PFE) has disclosed Gains from Investment Securities for 17 consecutive years, with $137.0 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities changed N/A to $137.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$165.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at -$165.0 million for FY2025, 104.58% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was $137.0 million at Pfizer, up from -$3.8 billion in the prior quarter.
  • The five-year high for Gains from Investment Securities was $3.9 billion in Q3 2022, with the low at -$3.8 billion in Q3 2025.
  • Average Gains from Investment Securities over 5 years is $841.2 million, with a median of $200.0 million recorded in 2022.
  • Peak annual rise in Gains from Investment Securities hit 4602.0% in 2021, while the deepest fall reached 779.17% in 2021.
  • Over 5 years, Gains from Investment Securities stood at $2.9 billion in 2021, then tumbled by 93.2% to $200.0 million in 2022, then tumbled by 1464.0% to -$2.7 billion in 2023, then skyrocketed by 216.28% to $3.2 billion in 2024, then tumbled by 95.68% to $137.0 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $137.0 million, -$3.8 billion, and $3.3 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.